Mitochondrial function in skeletal myofibers is controlled by a TRF2‐SIRT3 axis over lifetime
Jérôme D. Robin, Maria Sol Jacome Burbano, Han Peng, Olivier Croce, J.L. Thomas, Camille Laberthonnìère, Valérie Renault, Liudmyla Lototska, Mélanie Pousse, Florent Tessier, Serge Bauwens, Waiian Leong, Sabrina Sacconi, Laurent Schaeffer, Frédérique Magdinier, Jing Ye, Éric Gilson
Abstract
Telomere shortening follows a developmentally regulated process that leads to replicative senescence of dividing cells. However, whether telomere changes are involved in postmitotic cell function and aging remains elusive. In this study, we discovered that the level of the TRF2 protein, a key telomere-capping protein, declines in human skeletal muscle over lifetime. In cultured human myotubes, TRF2 downregulation did not trigger telomere dysfunction, but suppressed expression of the mitochondrial Sirtuin 3 gene (SIRT3) leading to mitochondrial respiration dysfunction and increased levels of reactive oxygen species. Importantly, restoring the Sirt3 level in TRF2-compromised myotubes fully rescued mitochondrial functions. Finally, targeted ablation of the Terf2 gene in mouse skeletal muscle leads to mitochondrial dysfunction and sirt3 downregulation similarly to those of TRF2-compromised human myotubes. Altogether, these results reveal a TRF2-SIRT3 axis controlling muscle mitochondrial function. We propose that this axis connects developmentally regulated telomere changes to muscle redox metabolism.